Alternative Splicing in the HumanPMP22Gene: Implications in CMT1A Neuropathy-Reference-Cited by-同舟云学术

Alternative Splicing in the HumanPMP22Gene: Implications in CMT1A Neuropathy

Published:2015-11-05 Issue:1 Volume:37 Page:98-109
ISSN:1059-7794
Container-title:Human Mutation
language:en
Short-container-title:Human Mutation

Author:

Visigalli Davide¹,Castagnola Patrizio²,Capodivento Giovanna¹,Geroldi Alessandro³,Bellone Emilia³,Mancardi Gianluigi¹,Pareyson Davide⁴,Schenone Angelo¹,Nobbio Lucilla¹

Affiliation:

1. Department of Neurosciences; Rehabilitation Ophthalmology; Genetics and Maternal-Infantile Sciences (DINOGMI) and CEBR; University of Genoa; Genoa Italy

2. IRCCS AOU San Martino - IST; Genoa Italy

3. Department of Neurosciences; Rehabilitation Ophthalmology; Genetics and Maternal-Infantile Sciences (DINOGMI) - Section of Medical Genetics; University of Genoa IRCCS AOU San Martino-IST; UOC Medical Genetics; Genoa Italy

4. Clinic of Central and Peripheral Degenerative Neuropathies Unit; IRCCS Foundation; C. Besta Neurological Institute; Milan Italy

Publisher

Wiley

Subject

Genetics(clinical),Genetics

Reference68 articles.

1. Human QKI, a potential regulator of mRNA expression of human oligodendrocyte-related genes involved in schizophrenia;Aberg;Proc Natl Acad Sci USA,2006

2. Ultrastructural immunocytochemical abnormalities of peripheral myelin proteins in hereditary sensory-motor neuropathies: 12 cases;Anani;Ann N Y Acad Sci,1999

3. Genetic spectrum of hereditary neuropathies with onset in the first year of life;Baets;Brain,2011

4. Messenger RNA processing is altered in autosomal dominant leukodystrophy;Bartoletti-Stella;Hum Mol Genet,2015

5. Mutation analysis of MFN2, GJB1, MPZ and PMP22 in Italian patients with axonal charcot-marie-tooth disease;Bergamin;Neuromolecular Med,2014

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Using RNA-targeting CRISPR-Cas13 and engineered U1 systems to reduceABCA4splice variants in Stargardt disease;2024-03-09

2. Genetic mechanisms of peripheral nerve disease;Neuroscience Letters;2021-01

3. Exploiting Sphingo- and Glycerophospholipid Impairment to Select Effective Drugs and Biomarkers for CMT1A;Frontiers in Neurology;2020-08-25

4. Schwann cell transcript biomarkers for hereditary neuropathy skin biopsies;Annals of Neurology;2019-04-22

5. Early short-term PXT3003 combinational therapy delays disease onset in a transgenic rat model of Charcot-Marie-Tooth disease 1A (CMT1A);PLOS ONE;2019-01-16